704 related articles for article (PubMed ID: 27712625)
1. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response.
Kindler E; Thiel V; Weber F
Adv Virus Res; 2016; 96():219-243. PubMed ID: 27712625
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection.
Comar CE; Goldstein SA; Li Y; Yount B; Baric RS; Weiss SR
mBio; 2019 Mar; 10(2):. PubMed ID: 30914508
[TBL] [Abstract][Full Text] [Related]
3. Molecular Basis of Coronavirus Virulence and Vaccine Development.
Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
[TBL] [Abstract][Full Text] [Related]
4. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.
Lui PY; Wong LY; Fung CL; Siu KL; Yeung ML; Yuen KS; Chan CP; Woo PC; Yuen KY; Jin DY
Emerg Microbes Infect; 2016 Apr; 5(4):e39. PubMed ID: 27094905
[TBL] [Abstract][Full Text] [Related]
5. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
Motavalli R; Abdelbasset WK; Rahman HS; Achmad MH; Sergeevna NK; Zekiy AO; Adili A; Khiavi FM; Marofi F; Yousefi M; Ghoreishizadeh S; Shomali N; Etemadi J; Jarahian M
IUBMB Life; 2021 Aug; 73(8):1005-1015. PubMed ID: 34118117
[TBL] [Abstract][Full Text] [Related]
6. SARS and MERS: recent insights into emerging coronaviruses.
de Wit E; van Doremalen N; Falzarano D; Munster VJ
Nat Rev Microbiol; 2016 Aug; 14(8):523-34. PubMed ID: 27344959
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
[TBL] [Abstract][Full Text] [Related]
8. Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.
Yuan H; You J; You H; Zheng C
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997210
[TBL] [Abstract][Full Text] [Related]
9. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
10. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
11. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
Kouwaki T; Nishimura T; Wang G; Oshiumi H
Front Immunol; 2021; 12():700926. PubMed ID: 34249006
[TBL] [Abstract][Full Text] [Related]
12. From SARS to MERS, Thrusting Coronaviruses into the Spotlight.
Song Z; Xu Y; Bao L; Zhang L; Yu P; Qu Y; Zhu H; Zhao W; Han Y; Qin C
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646565
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the immune response by Middle East respiratory syndrome coronavirus.
Shokri S; Mahmoudvand S; Taherkhani R; Farshadpour F
J Cell Physiol; 2019 Mar; 234(3):2143-2151. PubMed ID: 30146782
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting.
Abdirizak F; Lewis R; Chowell G
Theor Biol Med Model; 2019 Oct; 16(1):16. PubMed ID: 31587665
[TBL] [Abstract][Full Text] [Related]
15. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
[TBL] [Abstract][Full Text] [Related]
16. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
[TBL] [Abstract][Full Text] [Related]
17. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets.
Yang Y; Ye F; Zhu N; Wang W; Deng Y; Zhao Z; Tan W
Sci Rep; 2015 Dec; 5():17554. PubMed ID: 26631542
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview.
Rabaan AA; Al-Ahmed SH; Haque S; Sah R; Tiwari R; Malik YS; Dhama K; Yatoo MI; Bonilla-Aldana DK; Rodriguez-Morales AJ
Infez Med; 2020 Ahead Of Print Jun 1; 28(2):174-184. PubMed ID: 32275259
[TBL] [Abstract][Full Text] [Related]
19. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of emerging coronavirus infections.
Gralinski LE; Baric RS
J Pathol; 2015 Jan; 235(2):185-95. PubMed ID: 25270030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
